FibroGen (FGEN) Misses Q3 EPS by 15c

FibroGen (NASDAQ: FGEN) reported Q3 EPS of ($0.50), $0.15 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $29.03 million versus the consensus estimate of $36.48 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• H.B. Fuller makes £715M cash offer to acquire Advanced Medical Solutions
• MillerKnoll, Inc. (MLKN) Tops Q4 EPS by 4c